Brief: Newamsterdam Pharma Announces Appointment Of Ian Somaiya As Chief Financial Officer
23/10/2023 13:25
Oct 23 (Reuters) - NewAmsterdam Pharma Company NV
NAMS.O :
* NEWAMSTERDAM PHARMA ANNOUNCES APPOINTMENT OF IAN SOMAIYA
AS
CHIEF FINANCIAL OFFICER
Source text for Eikon: ID:nGNX5CVYqx
Further company coverage: NAMS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NewAmsterdam Pharma
See all newsBrief: Menarini Group & Newamsterdam Pharma Receive European Commission Approval For Ubeslo And Evlarco
Amgen falls after Novartis trial setback, BMO downgrade
Brief: Newamsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Newamsterdam Pharma Company N.V. - Announces Positive CHMP Opinion For Obicetrapib And Obicetrapib/Ezetimibe
Brief: NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)